Cargando…

A study on the association of serum fibroblast growth factor-23 with various indices of chronic kidney disease patients not yet on dialysis

Introduction: Fibroblast growth factor-23 (FGF23) is found as a bone derived hormone which can influence the serum levels of parathormone, phosphorous and 1, 25-dihydroxyvitamin D. FGF23 may be a cardiovascular biomarker in patients with chronic kidney disease (CKD). While, FGF23 is inversely correl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yaghoubi, Fatemeh, Ahmadi, Farrokhleghah, Lesanpezeshki, Mahboub, Mahdavi Mazde, Mitra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nickan Research Institute 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962669/ https://www.ncbi.nlm.nih.gov/pubmed/27471744 http://dx.doi.org/10.15171/jrip.2016.22

Ejemplares similares

Efficacy of HBV Vaccination in Various Stages of Chronic Kidney Disease: Is Earlier Better?
por: Hashemi, Behnam, et al.
Publicado: (2011)

Prognostic Importance of Fibroblast Growth Factor-23 in Dialysis Patients
por: Akalin, Nilgül, et al.
Publicado: (2014)

Sarcopenia in patients with chronic kidney disease not yet on dialysis: Analysis of the prevalence and associated factors
por: de Souza, Viviane Angelina, et al.
Publicado: (2017)

Urgent start peritoneal dialysis: are we there yet?
por: Greenberg, Keiko I., et al.
Publicado: (2020)

Fibroblast Growth Factor-23 in Pre-Dialysis Chronic Kidney Disease Patients and its Correlation with Carotid Artery Calcification
por: Kumar, Tarun, et al.
Publicado: (2022)

FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis
por: Lima, Florence, et al.
Publicado: (2014)

Relationship Between Serum Cystatin C and Creatinine or Dialysis Adequacy in Patients on Chronic Maintenance Hemodialysis
por: Khorgami, Zhinoos, et al.
Publicado: (2013)

The relationship between serum levels of fibroblast growth factor 21 and diabetic retinopathy
por: Mousavi, Zohre, et al.
Publicado: (2017)

Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional study
por: Nakayama, Masaru, et al.
Publicado: (2013)

Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study
por: Usui, Tomoko, et al.
Publicado: (2020)

Cost-effectiveness of phosphate binders among patients with chronic kidney disease not yet on dialysis: a long way to go
por: Rizk, Rana
Publicado: (2016)

Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer
por: Ghorbanihaghjo, Amir, et al.
Publicado: (2018)

Comparison of various indices for predicting sarcopenia and its components in patients receiving peritoneal dialysis
por: Do, Jun Young, et al.
Publicado: (2022)

Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease
por: Lin, Yu-Li, et al.
Publicado: (2021)

UPDATE ON FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE
por: Wolf, Myles
Publicado: (2012)

Comparison of Serum and Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL) With Serum Creatinine in Prediction of Kidney Suitability for Transplantation
por: Mahdavi-Mazdeh, Mitra, et al.
Publicado: (2012)

Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients
por: Sharma, Shailendra, et al.
Publicado: (2013)

Renal safety and urate-lowering efficacy of febuxostat in gout patients with stage 4–5 chronic kidney disease not yet on dialysis
por: Kim, Sang-Hyon, et al.
Publicado: (2020)

New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis
por: Mace, Maria L., et al.
Publicado: (2020)

Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants
por: Enlund-Cerullo, Maria, et al.
Publicado: (2023)

Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor‐23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease
por: Parker, V.J., et al.
Publicado: (2017)

Association between serum fibroblast growth factor‐23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease
por: Miyakawa, Hirosumi, et al.
Publicado: (2021)

Multiparametric cystoscopy: is the future here yet?
por: Ahmadi, Hamed, et al.
Publicado: (2021)

Associations of serum soluble klotho and fibroblast growth factor 23 with carotid artery calcification in patients undergoing continuous ambulatory peritoneal dialysis: A retrospective study
por: Guo, Naifeng, et al.
Publicado: (2021)

Serum Endocrine Fibroblast Growth Factors as Potential Biomarkers for Chronic Kidney Disease and Various Metabolic Dysfunctions in Aged Patients
por: Yamamoto, Shogo, et al.
Publicado: (2020)

Serum intact fibroblast growth factor 23 in healthy paediatric population
por: Stanczyk, Malgorzata, et al.
Publicado: (2021)

Fibroblast Growth Factor‐23 Concentration in Dogs with Chronic Kidney Disease
por: Harjes, L.M., et al.
Publicado: (2017)

Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation
por: Eisenga, Michele F., et al.
Publicado: (2020)

Role of fibroblast growth factor 23 in patients with chronic kidney disease
por: Wang, Song-Yan, et al.
Publicado: (2021)

Research progress of fibroblast growth factor 23 in acute kidney injury
por: Zhang, Lina, et al.
Publicado: (2022)

Pro/con debate: Continuous versus intermittent dialysis for acute kidney injury: a never-ending story yet approaching the finish?
por: Vanholder, Raymond, et al.
Publicado: (2011)

EUS in hepatology: Yet to find appropriate indications and patients
por: Kale, Aditya, et al.
Publicado: (2023)

Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model
por: Sugiura, Hidekazu, et al.
Publicado: (2018)

Indicators of Mental Health in Various Iranian Populations
por: Mohamadi, Khosro, et al.
Publicado: (2014)

Fibroblast Growth Factor 23 and Mortality Among Prevalent Hemodialysis Patients in the Japan Dialysis Outcomes and Practice Patterns Study
por: Komaba, Hirotaka, et al.
Publicado: (2020)

Fibroblast growth factor 23 and kidney function in patients with type 1 diabetes
por: Takashi, Yuichi, et al.
Publicado: (2022)

Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus
por: He, Xingxing, et al.
Publicado: (2017)

The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio Is a Useful Marker of Atherosclerosis in Early-Stage Chronic Kidney Disease
por: Yamada, Hodaka, et al.
Publicado: (2016)

Cost-effectiveness analysis of dialysis and kidney transplant in patients with renal impairment using disability adjusted life years in Iran
por: YaghoubiFard, Safiye, et al.
Publicado: (2016)

Cinacalcet lowering of serum fibroblast growth factor-23 concentration may be independent from serum Ca, P, PTH and dose of active vitamin D in peritoneal dialysis patients: a randomized controlled study
por: Kim, Hyo Jin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_35jvjansrg7tr63932n9q0b3p3